natalie callander, md, discusses melflufen approval for relapsed/refractory multiple myeloma
Published 3 years ago • 109 plays • Length 3:15
Download video MP4
Download video MP3
Similar videos
-
2:39
natalie callander, md, on ocular toxicity in multiple myeloma treatment
-
57:14
myeloma crowd radio: natalie callander, md, university of wisconsin
-
21:15
mcrt webinar may 2020: diagnosis and staging of myeloma - dr. natalie callander
-
26:09
what's next? - natalie callander, md | rt salt lake city, utah oct 15, 2022
-
3:05
vaccinations & istopmm trial | natalie callander, md | ims 2022
-
3:35
dreamm trial update - blenrep in myeloma trials | natalie callander, md | ash 2021
-
1:01:43
healthtree podcast: kidney disease and multiple myeloma with natalie callander
-
22:08
why consider bone marrowtransplant? - natalie callander, md | mcrt webcast october 31 (1/10)
-
1:15
dr. callander on treatment considerations in multiple myeloma
-
1:15
dr. callander discusses combinations in multiple myeloma
-
1:40
dr. holstein discusses role of melflufen in myeloma
-
6:58
dr. holstein: targets of interest for the treatment of multiple myeloma
-
5:06
video: how is multiple myeloma treated?
-
1:07
toxicities associated with lenalidomide for multiple myeloma
-
2:15
novel immunotherapies for the treatment of multiple myeloma
-
1:14
tiffany: a multiple myeloma patient tells her clonoseq® mrd testing story (60 second version)
-
6:20
graham jackson, md: lenalidomide maintenance is effective in all types of myeloma patients
-
5:46
introduction to multiple myeloma
-
1:56
dr. anderson on how the definition of myeloma has changed
Clip.africa.com - Privacy-policy